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Background: Particulate air pollution in lung epithelial cells induces pathogenic endpoints like proliferation,
apoptosis, and pro-inflammatory reactions. The activation of the epidermal growth factor receptor (EGFR) is a key
event responsible for signalling events involving mitogen activated protein kinases specific for these endpoints. The
molecular events leading to receptor activation however are not well understood. These events are relevant for the
toxicological evaluation of inhalable particles as well as for potential preventive strategies in situations when
particulate air pollution cannot be avoided. The current study therefore had the objective to elucidate
membrane-coupled events leading to EGFR activation and the subsequent signalling cascade in lung epithelial
cells. Furthermore, we aimed to identify the molecular target of ectoine, a biophysical active substance which we
described to prevent carbon nanoparticle-induced lung inflammation.
Methods: Membrane signalling events were investigated in isolated lipid rafts from lung epithelial cells with regard
to lipid and protein content of the signalling platforms. Using positive and negative intervention approaches, lipid
raft changes, subsequent signalling events, and lung inflammation were investigated in vitro in lung epithelial cells
(RLE-6TN) and in vivo in exposed animals.
Results: Carbon nanoparticle treatment specifically led to an accumulation of ceramides in lipid rafts. Detailed
analyses demonstrated a causal link of ceramides and subsequent EGFR activation coupled with a loss of the
receptor in the lipid raft fractions. In vitro and in vivo investigations demonstrate the relevance of these events for
carbon nanoparticle-induced lung inflammation. Moreover, the compatible solute ectoine was able to prevent
ceramide-mediated EGFR phosphorylation and subsequent signalling as well as lung inflammation in vivo.
Conclusion: The data identify a so far unknown event in pro-inflammatory signalling and contribute to the
understanding of particle cell interaction and therefore to risk identification and risk assessment of inhalable
xenobiotics. Moreover, as this cellular reaction can be prevented by the well tolerated substance ectoine, a
molecular preventive strategy for susceptible persons against airway inflammation is proposed.
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The carbonaceous fraction of environmental pollution
has been described to be the main determinant for
adverse health effects due to exposure against airborne
xenobiotics [1]. In particular, combustion derived
nanoparticles are considered as a major component of
particulate matter responsible for the induction and
aggravation of diseases in humans [2]. Besides environ-
mental exposure routes, humans may also come in
contact with this kind of xenobiotics in the form of
carbon nanoparticles (CNP) which are produced in
combustion processes for technological applications.
Humans are therefore exposed to this kind of nanoparticles
in environmental as well as in occupational settings,
and exposure through inhalation has been associated
with severe outcomes like lung cancer, COPD, and
cardiovascular diseases [3].
A main mechanism determining the toxicity of inhaled
particles and causative for lung diseases but also for
systemic health effects is the inflammation of the air-
ways. As direct reaction on inhaled particles, the release
of inflammatory factors like interleukin-8 (IL-8) can be
triggered by a direct interaction of particles with lung
epithelial cells [4]. In this context, the activation of the
epidermal growth factor receptor (EGFR) appears to be
a key event responsible for the expression and release of
this pro-inflammatory chemokine which is responsible
for the recruitment of neutrophils in the lung [5]. The
activation of EGFR has been reported to be triggered by
air pollutants like ozone, diesel emission particles (DEP)
and tobacco smoke but also by pure CNP [6-8].
The release of pro-inflammatory IL-8 from human
bronchial epithelial cells has also been correlated to
oxidative events [9]. Several studies demonstrated that
oxidative stress is also involved in phosphorylation of
EGFR and the subsequent activation of signalling cas-
cades in tissues exposed to the environment like alveolar
or bronchial epithelia [10,11]. The initial link between
nanoparticle-derived reactive oxygen species (ROS) and
EGFR signalling, however, is so far not understood.
EGFR is known to be located in functional lipid
domains defined either by their protein components like
caveolin [12] or by their specific lipid composition like
enriched gangliosides [13]. Upon activation, either by
ligands or by oxidative stress, membrane rearrangement
at the level of lipids as well as of proteins occur and the
active receptor becomes internalized while the subse-
quent signalling cascade is initiated [14,15]. Although
some influence of nanoparticles on active mechanisms
of uptake and internalization as well as effects on the
membrane fluidity have been described [16], it is not
clear how nanoparticles interfere with membrane-
coupled signalling processes. For CNP, the influence of
ROS on membrane-coupled signalling has beendemonstrated [8]. However, it had to be demonstrated
in which way oxidative stress triggers these molecular
events.
Inflammatory reactions of the lung triggered by CNP
as environmental model particles can be prevented
in vivo by compounds of the group of compatible
solutes. Our earlier studies with rat lung epithelium
demonstrated that membrane-coupled pro-inflammatory
signalling resulting in the release of IL-8 is significantly
reduced in the presence of the compatible solute ectoine
[17]. More recently, we were able to show that similar
signalling events elicited by CNP, but also by pro-
inflammatory factors, in neutrophilic granulocytes can
be prevented by ectoine [18]. As these events in neutro-
phils result in the reduction of natural apoptosis, the
application of ectoine appears suitable for the treatment
of chronic neutrophilic inflammation in diseases like
COPD or fibrosis. Compatible solutes are low molecular
weight natural compounds which are produced by cells
in order to survive under stress conditions like high salt,
desiccation, or high temperature. Besides their function
to act as osmotic counterpart, these substances have
been described to stabilize macromolecules and to have
an impact on membrane fluidity [19-21]. The compatible
solute ectoine so far has been shown to prevent signalling
events triggered by UVA irradiation in skin epithelial
cells. This kind of environmental stress initiates pro-
inflammatory signalling via the induction of ROS in kera-
tinocytes [22]. As a consequence of this oxidative stress,
ceramides are generated by non-enzymatic degradation of
sphingomyelin as an immediate early reaction which is
followed by de novo synthesis of ceramides. In this
system, ectoine prevented the increase of ceramides by
UVA radiation within lipid rafts [23].
In the current work, we aimed to investigate mo-
lecular mechanisms of CNP-induced EGFR activation
linking the particle-associated oxidative stress and pro-
inflammatory signalling. Using the compatible solute
ectoine as a substance which is not considered to act
as an anti-oxidant but is known to interfere in a bio-
physical way with lipid raft signalling [23], we asked
whether CNP specifically (compared to non-nano car-
bon particles, CP) induce changes in membrane com-
position that result in the activation of EGFR. For this
purpose, detergent resistant membranes (DRM) from
lung epithelial cells treated with either CNP or CP
were isolated and analyzed for their lipid and protein
composition. Such changes at the level of lipid rafts
were causally linked to signalling pathways responsible
for pathogenic endpoints which we identified in vivo
in animal experiments. Moreover, the molecular
mechanisms for the preventive effect of ectoine on
membrane-linked signalling events were investigated in
the current study.
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CNP increase ceramide levels in lipid raft membrane
fractions
In a first approach, possible changes in the lipid com-
position of detergent resistant membrane (DRM) frac-
tions, as equivalents of lipid rafts, triggered by CNP in
epithelial cells (RLE-6TN) were studied. Treatment of
lung epithelial cells within minutes leads to an activa-
tion of membrane-coupled signalling cascades involving
src family kinases (SFK) and mitogen activated protein
kinases (MAPK; 25). Therefore, initial events at the
level of the membrane were investigated in DRM iso-
lated by density centrifugation from cells treated with
particles for 5 minutes. The particle dose of 10 μg/cm2
has been chosen as an equivalent of a cumulative
environmental exposure dose which has been shown
earlier to induce MAPK activation in lung epithelia
in vitro. Such treatment, however, does not induce
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Figure 1 CNP trigger lipid changes in rafts and subsequent EGFR and
5 min] or the indicated doses of C6 ceramide [μM, 15 min] respectively. (A
detected after HPTLC. (B) Phosphorylation of EGFR at Tyr1173, (C + D) SFK a
phospho-specific antibodies. Equal loading was confirmed with GAPDH or
control, † significantly different from CNP-treatments without C32 pre-treatearly response on the particle treatment, in high per-
formance thin layer chromatography (HPTLC) analyses
(Figure 1A) the ceramide content was increased while the
amounts of ganglioside GM3 and sphingomyelin were
significantly decreased. This decrease was accompanied
by a loss of cholesterol in lipid rafts.
Phosphorylation of EGFR and SFK is specifically triggered
by CNP and ceramide
In a next set of experiments the possible key function of
ceramides for CNP-triggered signalling was tested in
lung epithelial cells treated with CNP [10 μg/cm2] or
increasing doses of externally added C6 ceramide. Both
treatments led to the activating phosphorylation of
EGFR at position Tyr1173 (Figure 1B). The dose
dependent increase in Tyr1173 phosphorylation proved to
be significant in a correlation analysis (Pearson, r=0.58,
p=0.004). In order to link this reaction with membrane
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SFK activation. RLE-6TN cells were incubated with CNP [10 μg/cm2,
) Amount of ceramide, GM3, sphingomyelin, and cholesterol was
t Tyr416, and (E) ERK1/2 determined by Western Blot using
total EGFR. C32, compound 32, * significantly different from respective
ment [10 μM, 1 h].
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investigated the effects of ceramide on the activation of
SFK and the MAPK Erk1/2. The described cell treat-
ments resulted in significant increases of the activating
phosphorylation of SFK at tyrosine residue 416 (Tyr416),
both, by ceramide (Pearson correlation, r=0.65, p=0.002)
and CNP (Figure 1C). In an additional experiment using
the pharmacological EGFR inhibitor compound 32, the
causal connection of EGFR activity and SFK phosphoryl-
ation was demonstrated by a significant reduction of
SFK phosphorylation in cells treated with CNP in the
presence of the inhibitor (Figure 1D). As the central
signalling step causally linked to EGFR and SFK activa-
tion [24,25] Erk1/2 phosphorylation was investigated
(Figure 1E). Again the application of C6 ceramide
[5 μM] led to an increase in Erk1/2 phosphorylation
which was comparable to the reaction in response to
CNP, demonstrating the ability of nanoparticle-triggered
ceramide to induce this signalling step. Together with














































































































































Figure 2 CNP induce loss of SFK and EGFR from lipid rafts. (A) RLE-6TN
CP [10 μg/cm2, 5 min] and raft and non-raft fractions were isolated and po
Western Blot analyses using total SFK or EGFR antibodies were performed.
were treated with CNP [10 μg/cm2, 5 min], CP [10 μg/cm2, 5 min], ectoine
localization was analyzed by immunostaining and fluorescence microscopyupstream protein component of the described nanoparticle
specific signalling pathway activated by ceramides.
EGFR and SFK disappear from lipid rafts after activation
by CNP and ceramide
In order to investigate the influence of CNP on signal-
ling events arising in lipid rafts, DRM from differently
treated cells were analyzed for the specific occurrence
of signalling proteins by Western blotting of the
respective raft and non-raft fractions (Figure 2A). The
treatment of cells with particles or control substances
had no effect on the integrity of lipid rafts (Additional
file 1: Figure S2). Despite the lack of difference in
the total protein amount, the signalling proteins SFK
and EGFR were significantly reduced in raft fractions
from cells treated with CNP, indicating the activation
and translocation of the EGFR signalling complex.
Importantly, such an event was not observed when the
cells were treated with similar mass doses of CP, indi-





cells were treated with CNP [10 μg/cm2, 5 min], C6 [5 μM, 15 min], or
oled according to the scheme depicted in the supplementary material.
*, Significantly different to PBS control (p < 0.05). (B) RLE-6TN cells
[1 mM, 4 h pre-treatment] + CNP, or C6 [5 μM, 15 min]. EGFR (red)












































































Figure 3 Ceramide-dependent signalling steps are associated
with lung inflammation in mice. Activation of signalling steps in
lung homogenate and induction of inflammation determined in BAL
in mice (n = 5) treated with PBS, CNP [5 mg/kg bodyweight], or CNP
together with ectoine [E, 1 mM]. (A) Phospho-EGFR at Tyr1173 signals
relative to total EGFR signals. (B) Phospho-SFK at Tyr416 signals
relative to GAPDH signals. (C) Neutrophilic granulocytes in BAL (D)
KC in BAL. *, Significantly different from control; †, significantly
different from CNP alone (p < 0.05).
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reactivity. As a proof of principle for the described
signalling events, the translocation of SFK and EGFR in
cells treated with C6 ceramide [5 μM] was also
observed. The cellular fate of EGFR after activation was
investigated microscopically after EGFR immunostaining
(Figure 2B). While in the control cells a clear membrane
localization of EGFR was observed, the treatment with
CNP or with C6 ceramide resulted in an internalization
of the receptor. The treatment with the non-nano CP had
no effect on the EGFR translocation.
In this set of experiments (Figure 2B), the preventive
effect of the compatible solute ectoine on the activation
of EGFR was also tested. Earlier studies have shown that
ectoine effects are very unlikely to be mediated by
changes in particle properties [17]. Pre-treatment of the
cells with 1 mM ectoine clearly reduced the translocation
of the receptor either induced by CNP or by ceramide.
Therefore, the current data indicate that very early reac-
tions are prevented by this compatible solute at the level
of membrane-coupled signalling.
EGFR and SFK signalling in vivo
The physiological relevance of the so far identified
membrane-dependent signalling was next investigated
in vivo in animal experiments in which C57BL/6 mice
were exposed to CNP suspensions via pharyngeal aspir-
ation (Figure 3). After 24 h a significant increase of
EGFR at position Tyr1173 was observed in the lung
tissue (Figure 3A). Accordingly, SFK phosphorylation
(Tyr416) occurred in the lungs of the same animals
(Figure 3B). These signalling events were reflected by
the induction of neutrophilic inflammation measured by
the percentage of neutrophils per ml lavage (Figure 3C)
but also by the increase of neutrophil recruiting
chemokine KC (IL-8 equivalent in mice; Figure 3D). As
an intervention strategy for the identified signalling
triggered by nanoparticle derived ceramide, 1 mM
ectoine was applied together with CNP. This treatment
was able to significantly reduce pathogenic cell stress
events at the level of phosphorylation of signalling
proteins and consequently reduced lung inflammation
determined in BAL.
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be prevented by ectoine
EGFR activation and subsequent signalling cascades have
been correlated with CNP-induced intracellular oxida-
tive stress [8]. The next set of experiments, therefore,
aimed to investigate the link of CNP-induced lipid raft
signalling and ROS. Moreover, the identification of the
molecular targets of ectoine was intended.
As a first step, intracellular oxidative stress was mea-
sured flow cytometrically using dichlorofluoresceine (DCF,
Figure 4A). Cell treatment with 5 μg/cm2 and 10 μg/cm2
CNP resulted in a significant increase of intracellular fluor-
escence. Exposing cells to an equal mass dose [10 μg/cm2]
of CP did not lead to elevated ROS levels. An exposure
scenario based on equal surface area with CP (200 μg/cm2
CP versus 5 μg/cm2 CNP) led to a significant ROS induc-
tion by CP which, however, was markedly lower than with
CNP. In order to control for possible changes in surface
properties by particle protein interaction, CNP were pre-
incubated with [1 μg/ml] bovine serum albumine prior to
cell exposure. This kind of treatment led to a change in
the zeta potential of the particles but did not significantly
change the particle aggregate size (Additional file 1: Table
S1). Protein coated particles also increased DCF fluores-
cence significantly. Scavenging ROS at the level of the
membrane by adding tocopherol [50 μM] or increasing
the antioxidant capacity of the cells by pre-incubation
with N-acetylcysteine (NAC) [0.1 mM] both significantly
reduced CNP-specific DCF fluorescence. Ectoine is not
considered as a ROS-scavenging substance and therefore
has no influence on CNP-specific intracellular oxidative
stress. As ceramides are hypothesized to be generated as
a consequence of ROS, the lack of DCF fluorescence in
C6-treated cells was expected.
The specificity of the ceramide generation by CNP was
investigated in additional HPTLC assays monitoring
ceramide contents in lipid rafts (Figure 4B). CP which
did also not trigger oxidative stress, had no effect on the
ceramide levels of lipid rafts. Accordingly, in cells pre-
treated with tocopherol, CNP did not induce increased
ceramide levels. Both results corroborate earlier find-
ings that show a ROS-dependent and probably non-
enzymatic generation of ceramides [22,23]. Ectoine,
however, which has no ROS scavenging properties
(Figure 4A), also slightly reduced ceramide levels in
lipid rafts. This finding may indicate an unexpected
mechanism counteracting ceramide generation which
is different from antioxidants.
Further on, the influence of both antioxidant strategies
as well as of ectoine on the cellular translocation of
EGFR was investigated in raft and non-raft membrane
fractions of exposed cells (Figure 4C). The loss of EGFR
from raft fractions induced by the CNP treatment, which
we describe here as a consequence of ceramidegeneration, is significantly reduced in cells pre-treated
with either antioxidants or ectoine. In this experiment
however it can be observed that tocopherol alone has
also an influence on the localization of EGFR in the raft
fractions. Furthermore, ectoine in CNP-treated cells not
only increased the amount of EGFR in the non-raft frac-
tions but also appeared to enhance EGFR stability in the
non-raft fractions.
Finally, the link between oxidative stress and subsequent
ceramide generation and the activation of EGFR was tested
by measuring EGFR phosphorylation in the presence of
NAC and tocopherol as quenchers of oxidative stress and
ectoine as an inhibitor of ceramide accumulation in the
lipid raft (Figure 4D). All intervention strategies led to a
reduction of EGFR phosphorylation. In addition, the treat-
ment with CP, again, demonstrates the specificity of this
endpoint for nanosize carbon particles.
Discussion
Ceramides as components of lipid raft signalling by
carbon nanoparticles
The generation of ceramide as an intermediate of sphingo-
lipid metabolism has been suggested to cause pulmonary
diseases triggered by xenobiotic stress like cigarette smoke
[7]. Ceramides acting as second messenger are able to
induce apoptotic processes responsible for the induction
or the aggravation of acute lung injury, which may result
in emphysema and COPD [26]. The current data, how-
ever, are indicative for another mechanism of ceramide
action in the pathogenesis of lung diseases which is
relevant for exposure to the carbonaceous core fraction of
combustion derived nanoparticles. Pure CNP trigger the
accumulation of ceramides in lipid raft signalling
domains. First results indicating the possibility of such a
mechanism came from adenocarcinoma cells in which
oxidative stress led to a co-localization of ceramides and
activated EGFR and SFK [27]. The authors postulate a
rearrangement of lipid rafts mediated by ceramides which
is responsible for the activation of EGFR. Our data, in
fact, demonstrate that an increase of ceramides in these
membrane fractions initially causes the activation of
signalling cascades via EGFR in lung epithelium and sub-
sequently is responsible for the induction of neutrophilic
lung inflammation in vivo. The induction of this signal-
ling cascade by the externally added C6 ceramide gives
evidence that ceramides are key molecules in this
xenobiotic-induced adverse signalling.
Oxidative stress specifically triggered by nanoparticles
causes lipid raft signalling
The studies presented here identify the generation
of intracellular oxidative stress as the initial event in a
cascade of membrane signalling events involving the accu-



























































































































Figure 4 Ectoine as well as antioxidants prevent ceramide generation and subsequent receptor translocation. (A) Flow cytometric
analysis of intracellular ROS generation in RLE-6TN cells measured by relative intracellular DCF fluorescence after treatment with the indicated
doses of CNP [μg/cm2, 1 h], CP [μg/cm2, 1 h], BSA-coated CNP, or C6 ceramide [5 μM, 15 min] and pre-treatment with the respective inhibitors
tocopherol [Toco; 50 μM] N-acetylcysteine [NAC; 0.1 mM], or ectoine [E; 1 mM]. C indicates respective vehicle controls. (B) Amount of ceramide
generation was detected by lipid extraction and HPTLC in RLE-6TN cells. (C) EGFR translocation as described in Figure 2 after treatment and
pre-treatment as described above. (D) EGFR activation as described in Figure 1 after treatment and pre-treatment as described above. Means in
A, C, and D are given as values relative to the respective controls. *, Significantly different from control; †, significantly different from 10 μg/cm2
CNP alone; §, significantly different from C6 alone.
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triggering intracellular ROS, thus, may be considered as
determining for the subsequent adverse signalling. Pure
CNP are known to generate ROS due to their high surface
area and the specific surface reactivity [28]. Interestingly,CP which differ in primary particle size and in the specific
surface area per mass unit but appear to form aggregates
in the same size range as CNP failed to trigger this reac-
tions when applied as equal mass doses. As the exposure
experiments based on equal surface area did not reveal
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ation, we cannot exclude an additional particle character-
istic determining this reaction. However, it has to be
considered that in order to achieve equal surface area, un-
physiologically high mass doses of CP have to be applied.
Nanoparticle specific induction of ROS has also been
described for other poorly soluble nanoparticles with quite
different chemical composition [29]. Our own earlier data
indicated that the signalling cascade is also induced by
silica nanoparticles [24]. The relevance of the described
signalling events for other poorly soluble nanoparticles
appears likely and has to be demonstrated. Such investiga-
tions will be of particular interest with modern colloidal
nanoparticles which may have a low potential for ROS
generation. The activation of the EGFR as early event of
adverse particle effects has also been reported for diesel
particles [9]. In these studies, the main effects have been
attributed to the organic fraction of DEP. The particles
chosen in our experiments, however, are known to contain
low amounts of PAH (polycyclic aromatic hydrocarbons)
which are not easily mobilised and may not be responsible
for the effects which are observed after minutes [30]. We
therefore conclude that the signalling events can be
assigned to particulate nature of the applied xenobiotic.
Including recent and earlier data, we are now able to
postulate an initial signalling cascade mediating adverse
effects of CNP via MAPK. These signalling elements
have been described to mediate the endpoints apoptosis,
proliferation, and expression of pro-inflammatory cyto-
kines, respectively in lung epithelial cells exposed to
doses of CNP which in real life may be achieved by cu-
mulative environmental exposure [17,24,28]. Upstream
of MAPK activation, events of membrane coupled sig-
nalling have been identified to be specifically elicited by
CNP. Involving EGFR and integrins, CNP specifically
activate SFK and subsequently the signalling cascade via
phosphatidylinositol-3-kinase (PI3-K) and protein kinase
B (Akt; [25,31].
Compatible solutes prevent cell stress-triggered ceramide
signalling
Compatible solutes have been described to interact with
macromolecules via the biophysical mechanism of pre-
ferential exclusion [32]. Due to their mostly zwitter ionic
nature they interact with water molecules and indirectly
with hydration layers of soluble molecules [33]. It is
accepted that proteins in the presence of compatible
solutes shift into thermodynamically stable conforma-
tions. In vitro investigations on the fluidity of artificial
membranes indicate that the presence of these sub-
stances significantly changes this parameter [21]. The
data of the current study now demonstrate that these
biophysical molecular events which were mostly identi-
fied in cell free systems are relevant in lung epithelialcells and in the organ system of the lung. While ectoine
had no influence on the very initial event of intracellular
ROS generation, it had effects on the two subsequent
molecular events. (i) the accumulation of ceramides in
the lipid rafts after particle stressappears to be reduced
in the presence of ectoine, and (ii), more strikingly, the
ceramide-triggered phosphorylation and dislocation of
EGFR from the lipid rafts were reduced by ectoine as
shown by the experiments in which ceramide was added
externally. Accordingly, all subsequent signalling events
are also prevented by ectoine.
Ceramide mediated signalling as target of a preventive
molecular strategy
The signalling events described here which are mediated
by the accumulation of ceramides are of particular rele-
vance for individuals who are chronically exposed to
traffic related particulate air pollution. This kind of envir-
onmental xenobiotic has been associated with several
systemic adverse health effects in humans. In particular,
the occurrence of mild forms of COPD was observed in a
cohort with increased neutrophilic lung inflammation due
to long term exposure to this kind of air pollution [34].
Our own studies demonstrate that lung inflammation
dominated by neutrophilic granulocytes which is typical
for COPD is triggered by the carbonaceous core of these
environmental particles via the activation of MAPK path-
ways in lung epithelial cells [17]. The in vivo investigations
of this study demonstrate that the recently identified sig-
nalling events are of physiological relevance and that they
contribute to pathogenic outcomes like neutrophilic lung
inflammation. This fact is mainly demonstrated by the
preventive effect of ectoine on lung inflammation in mice
(and rats, as described earlier; 17) and appears to be
caused by the preventive effect on the activation of EGFR
and SFK in vivo. As nanoparticles of other chemical com-
position are likely to also trigger the signalling events
described in this study, ectoine may also prevent adverse
effects of these xenobiotics. Together with our more re-
cent findings showing that ectoine is also therapeutically
active at the level of neutrophilic granulocytes themselves
[18], the data of the actual study indicate that the applica-
tion of ectoine in human lungs may be beneficial in situa-
tions in which air pollution cannot be reduced by
technological measures or, more importantly, for persons
suffering from respiratory diseases.
Conclusions
The data presented here demonstrate the central role
of the accumulation of ceramides in the lipid raft frac-
tion of lung epithelial cells for the induction of pro-
inflammatory reactions and the development of lung
inflammation in response to environmental model par-
ticles. The activation of EGFR signalling in the lung by
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compounds or transition metals contaminating the par-
ticulate fraction of inhaled air pollution like PM or
tobacco smoke. Here we show that the pure carbon-
aceous fraction of inhaled particles is able to trigger
pathogenic responses of the epithelium employing a
lipid raft-dependent mechanism. Moreover, the compatible
solute ectoine is identified as a substance that specifically
prevents the described signalling events. The data there-
fore provide mechanistic insight into the molecular




Carbon nanoparticles (CNP, Printex 90) were obtained
from Degussa (Germany), and carbon particles (CP) were
from H. Haeffner (Chepstow, UK; as Huber 990). Stock
suspensions [1 mg/ml] of particles were prepared in PBS
by sonication for 60 min. Particles and particle suspen-
sions were characterized by (i) scanning electron micros-
copy (JSM 7000 F, JEOL Ltd., Japan), (ii) BET using
FlowSorb II 2300 analyzer (Micromeritics, Norcross,
USA), and (iii) light scattering using ZetratracTM
NPA152 (Microtrac, Montgomeryville, PA, USA). Particle
properties are listed in Table 1S (see Additional file 1).
Cell culture and exposure
The rat lung epithelial cell line RLE-6TN was purchased
from ATCC (Manassas, VA) and grown at 37°C, 5% CO2
in supplemented Ham's F-12 medium [24]. For experi-
ments, cells were grown to 80 – 90% confluence, then
starved for 20 h in serum reduced medium [0.5% FCS]
prior to particle exposure [10 μg/cm2]. Cells were treated
with CNP and CP for up to 1 h in the absence or pres-
ence of inhibitors. Inhibitors were added to the cells 18 h
(NAC), 4 h (ectoine), or 60 min (compound 32, alpha-
tocopherol) prior to treatment with CNP or C6 cera-
mide (N-hexanoyl-D-erythro-shingosine, Calbiochem,
Schwalbach, Germany). Alpha-tocopherol [50 μM] was
solubilized in ethanol (final ethanol concentration 0.03%).
C6 ceramide was solubilized in DMSO (final DMSO con-
centration 0.1%). In experiments using these compounds,
respective vehicle controls were performed. The effect of
DMSO on lipid raft composition was investigated in one
control experiment. DMSO treated samples showed no
difference to PBS treated samples.
Cytotoxiciy assay
Cell viability was evaluated by WST-1 (4-[3-(4-iodophenyl)-
2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate)
assay (Roche diagnostics, Mannheim, Germany) according
to the manufacturers’ instructions after 1 h exposure as
described above. Eight-fold measurements were performedin three independent (n=3) experiments. Viability was esti-
mated relative to medium (negative) controls and exposure
to NaN3 [1 M] as positive control.
Animal experiments
Female C57BL/6JRj mice (8 weeks old, Janvier, France)
were treated via pharyngeal aspiration with a volume of
50 μl suspension, under inhalation anaesthesia (isoflurane,
5%, 1–2 min). Animals were sacrificed by exsanguination
under anaesthesia 24 h after treatment. After broncho-
alveolar lavage (4 x 1 ml PBS), lung tissues were minced,
shock frozen and stored at −80°C until further use.
Differential cell counts were performed from Giemsa/
May-Grünwald stainings of lavage cells. Cell free lavage
fluids were subjected to solid-phase ELISA in order to de-
termine KC (R&D systems, Minneapolis, MN). All animal
experiments were performed after relevant permission
according to German animal protection laws.
Isolation of detergent resistant membrane raft fractions
Membrane fractions were isolated by density gradient
ultracentrifugation as described (22). Exposed cells were
harvested in 1 ml TNE buffer [50 mM Tris/HCl pH
7.4, 150 mM NaCl, 2 mM EDTA]. After Dounce
homogenization (25 strokes in 1 ml TNE), Triton X-100
was added (1% w/v final concentration). After 30 min on
ice the lysate was subjected to density centrifugation
(5-30-50% OptiPrep™, 40 000 rpm, rotor 50.2-Ti, 4 h at
4°C). Fractions (7 × 600 μl) were collected starting at
the top of each gradient.
Dot blot
Identification of raft fractions was performed by detection
of the raft marker ganglioside GM1 in 2 μl of each frac-
tion spotted on nitrocellulose by HRP-labelled cholera
toxin subunit B (1 h; Sigma, Germany). Signal strength
was detected using the ECL Plus Western Blotting Detec-
tion System (GE Healthcare, Buckinghamshire, UK).
Lipid extraction and high-performance thin layer
chromatography (HPTLC)
Both methods were performed according to Grether-
Beck et al. [23]. Briefly, quantification of lipids was
carried out using 500 mg protein for Folch extraction.
Ceramides need to be extracted from the biological
sample by alkaline hydrolysis, whereas sphingomyelin
and glycosphingolipids are extracted without the hydro-
lysation. After extraction, samples and standards were
separated on silica gel HPTLC plates using a stepwise
elution gradient with methanol, dichloromethane, and
n-hexane. Visualization of separated bands was carried
out by post-chromatic derivatisation after dipping in a
manganese chloride solution.
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Cells: After exposure, cells were washed twice with ice-
cold PBS and lysed in modified RIPA buffer [25 mM
Tris/HCl, pH 7.4, 150 mM NaCl, 0.1 mM EDTA, 1%
Nonidet P-40, 0.1% SDS, 1% deoxycholate, 0.025%
NaN3, 1% protease inhibitor cocktail, and 1% phosphat-
ase inhibitor cocktail]. Lung tissue: Minced tissue was
incubated with RIPA buffer and protein was isolated
using a pebble mill. After determination of protein
contents, equal amounts of total cell protein [5 – 40 μg]
were separated by SDS-PAGE [7.5 or 10%] and trans-
ferred onto PVDF membranes (Hybond-P, Amersham
Biosciences, Little Chalfont, UK). The following anti-
bodies were used: phospho-EGFR (Tyr1173), phospho
SFK (Tyr416), and phospho-p44/42 MAPK (Thr202/
Tyr204) (all from Cell Signalling Technology, Danvers,
MA), total EGFR (Upstate Biotechnology, Lake Placid,
NY), total SFK (Cell Signalling Technology), and
GAPDH (Imgenex Corp., San Diego, CA). Signal
strength was detected using the ECL Plus Western
Blotting Detection System. Band intensities from X-ray
films (immunosignal) were used for statistical calcula-
tions. The depicted graphs show immunosignals realtive
to the respective controls.
Immune staining
Cells were fixed with 4% paraformaldehyde for 15 min at
room temperature. After permeabilisation and blocking
(in 3% bovine serum albumin, 0.3% Triton X-100 in
PBS), cells were incubated with anti-EGFR antibody
(1:50; Cell Signalling Technology) overnight at 4°C. After
incubation with anti-rabbit Alexa Fluor 594-coupled
antibody (1 h, 1:500; Invitrogen, Darmstadt, Germany),
nuclei were counterstained with 40,6-diamidino-2-pheny-
lindole (1:2000, Invitrogen). Cells were visualized using
an Axiovert 40 microscope (Zeiss, Jena, Germany). As
control for the specificity of the reactions, mock immu-
nostainings without primary antibody were performed.
ROS detection
Cells were incubated for dye uptake with 20 μM of the
fluorogenic probe H2DCF-DA (2', 7'-Dichlorofluorescein
diacetate, Calbiochem, Schwalbach, Germany). Generation
of ROS was determined by flow cytometry according to
Weissenberg et al. [8].
Statistical analyses
In vitro experiments were repeated independently at
least three times; animal experiments were performed
with 5 animals per group. Unless otherwise stated,
results were analyzed by analysis of variance followed by
post-hoc testing. Differences between groups were con-
sidered as significant when p < 0.05.Additional file
Additional file 1: Exposure of cells to CNP or CP does not interfere
with viability measured by WST.
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